Cogent Biosciences's market cap is currently $893.64M. The company's EPS TTM is $-2.477; its P/E ratio is ―; Cogent Biosciences is scheduled to report earnings on March 18, 2025, and the estimated EPS forecast is $-0.59. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 7.87M	$ 22.50M
Gross Profit	$ -3.59M	$ -5.88M	$ -147.00K	$ 7.85M	$ 22.46M
Operating Income	$ -208.13M	$ -147.84M	$ -75.55M	$ -82.20M	$ -32.18M
EBITDA	$ -205.86M	$ -134.36M	$ -75.40M	$ -34.57M	$ -30.89M
Net Income	$ -192.41M	$ -132.64M	$ -71.81M	$ -66.45M	$ -30.27M
Balance Sheet
Cash & Short-Term Investments	$ 265.71M	$ 259.28M	$ 219.68M	$ 242.19M	$ 37.42M
Total Assets	$ 313.44M	$ 300.81M	$ 232.09M	$ 250.92M	$ 49.42M
Total Debt	$ 18.85M	$ 19.65M	$ 3.15M	$ 5.21M	$ 6.03M
Net Debt	$ -34.38M	$ -120.24M	$ -216.53M	$ -236.98M	$ -31.39M
Total Liabilities	$ 55.63M	$ 45.08M	$ 17.91M	$ 16.25M	$ 17.66M
Stockholders' Equity	$ 257.80M	$ 255.74M	$ 214.18M	$ 234.67M	$ 31.76M
Cash Flow
Free Cash Flow	$ -156.42M	$ -125.50M	$ -60.48M	$ -35.85M	$ -41.55M
Operating Cash Flow	$ -153.62M	$ -118.64M	$ -58.76M	$ -35.85M	$ -41.51M
Investing Cash Flow	$ -97.82M	$ -124.72M	$ -1.72M	$ 8.42M	$ 23.16M
Financing Cash Flow	$ 163.54M	$ 163.56M	$ 37.98M	$ 232.20M	$ 108.00K

Currency in USD

Cogent Biosciences Earnings and Revenue History

Income Statement >

Cogent Biosciences Debt to Assets

Balance Sheet >

Cogent Biosciences Cash Flow

Cash Flow >

Cogent Biosciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing